B
BnH Research
Contract-based research services delivering high-quality data for drug efficacy validation in CNS and cardiovascular disorders
About BnH Research
BnH Research is a specialized contract research organization (CRO) focused on providing high-quality data for the validation of drug efficacy, primarily in the early phases of drug discovery. The company serves pharmaceutical companies that are in need of reliable data to support their drug development processes, particularly in areas that have seen reduced focus from larger pharmaceutical firms. BnH Research operates in the central nervous system (CNS) and cardiovascular disease markets, addressing unmet needs in these therapeutic areas. The business model is contract-based, meaning they generate revenue by offering their research services to pharmaceutical companies on a project basis. This includes lead selection optimization and mechanism studies, which are crucial for the development of new drugs. The company also has a pipeline of drug candidates aimed at reopening cortical plasticity, which has applications in treating brain diseases and enhancing cognition.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Chuncheon, South Korea
- Open positions
- None listed
- Dealroom signal
- 15.7/100
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Mar 2022 | $10M | $40M | UTC Investment · LSK Investment · CKD Venture Capital Corporation · Honest Ventures | ↗ |
| SERIES AOther financing | Jun 2020 | $4.6M | $18M | KB Securities · Albatros Investment · UTC Investment · LSK Investment | ↗ |
Growth signals
Latest recorded traffic for BnH Research is 2.8K monthly website visits, up 16.7% over the last three months.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
KB Securities
Albatros Investment
UTC Investment- LILSK Investment
- CCCKD Venture Capital Corporation
Honest Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about BnH Research on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BnH Research’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.